TKPHF - Takeda Pharmaceutical Non-GAAP EPS of ¥484.00 revenue of ¥4263.8B; initiates FY24 outlook
2024-05-09 02:15:17 ET
More on Takeda Pharmaceutical
- Takeda Pharmaceutical: Eohilia's FDA Approval Brings Tailwinds
- Takeda Pharmaceutical Company: Attractive Stock But Needs To Grow Net Profits
- New house bill to extend COVID-era telehealth flexibilities
- Bristol, Sanofi, Takeda gain positive CHMP recommendations
- Seeking Alpha’s Quant Rating on Takeda Pharmaceutical